Kathleen Reape's most recent trade in Taysha Gene Therapies Inc was a trade of 36,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 22, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies Inc | Kathleen Reape | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 36,200 | 36,200 | - | - | Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Kathleen Reape | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 15,500 | 15,500 | - | - | Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Kathleen Reape | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,500 | 15,500 | - | - | Stock Option (right to buy) |